Advertisement
"To meet the unique needs of small and mid-size biopharmaceuticalcompanies conducting more complex, global clinical programs, the new featuresof the TrialWorks system provide a greater degree of flexibility andconfigurability for these demanding studies," said Steve Kent, President ofPerceptive Informatics. "Since CTMS tracks, manages, and reports on everyaspect of a clinical study, we believe it is a critical component of anoverall eClinical solution that is needed to maximize the productivity andefficiency of clinical research."
Advertisement
The TrialWorks solution, which is part of Perceptive Informatics'industry-leading eClinical capabilities, is integrated with other eClinicalsystems including Interactive Voice and Web Response Systems (IVRS/IWRS) andElectronic Data Capture (EDC). The TrialWorks solution provides fullvisibility into clinical trial information and helps to streamline processes.The system, which is built to meet specific needs of small and mid-sizebiopharmaceutical companies and their service providers, supports clinicaltrials of all sizes, from single site studies to multi-national programs. TheTrialWorks solution provides comprehensive trial management data for theentire clinical team, from consolidated metrics for senior management toreports for project teams. It delivers relevant information to all studystakeholders, promotes operational and workflow standards, and helps to ensuretimely investigator payments as well as accurate financial reporting. Thesystem also provides online and offline access to clinical monitors.
New enhancements to the TrialWorks solution include:
-- "My Reports" - with over 175 standard reports tailored for keydepartments and an ad-hoc reporting component, this feature now allows usersand project teams to more easily access and share frequently used reports,saving time and creating a more organized reporting environment
-- Compatibility with new requirements of the ClinicalTrials.gov website,and ability to export files for import into ClinicalTrials.gov
-- New options to classify studies, offering greater flexibility ingrouping studies together, as well as enhancements for more detailed filteringand analysis of study information
Additionally, a new web interface for the Universal Data Transfer Tool,which can be used in conjunction with the TrialWorks solution, provides a morestreamlined transfer of patient and visit data as well as Case Report Form(CRF) status from other systems.
The TrialWorks solution, previously part of the ClinPhone productportfolio, has been used for thousands of clinical trials. The system, whichhas a user-friendly and intuitive interface, can be rapidly implementedcompany-wide. The TrialWorks solution can be licensed and installed, orimplemented as a hosted solution.
About Perceptive Informatics
Perceptive Informatics, a subsidiary of PAREXEL, is one of the industry'sleading eClinical technology providers. Perceptive Informatics offersunprecedented access to innovative eClinical technologies and resources,providing clinical trial sponsors, CROs, and other service providers with thebenefits of an extensive line of products and services throughout the entireclinical development lifecycle. In August, 2008 Perceptive was joined withClinPhone plc, and the newly combined organization offers best-in-classeClinical software and services that increase the efficiency and productivityof clinical research. Perceptive's expansive product portfolio includesInteractive Voice and Web Response Systems (IVRS/IWRS,) Medical Imaging,Electronic Data Capture (EDC) systems, Clinical Trial Management Systems(CTMS) and Electronic Patient Reported Outcomes (ePRO) solutions, as well aseClinical systems integration and implementation services. For moreinformation about Perceptive Informatics, visit www.perceptive.com.
About PAREXEL
PAREXEL International Corporation is a leading global biopharmaceuticalservices organization, providing a broad range of knowledge-based contractresearch, medical communications and consulting services to the worldwidepharmaceutical, biotechnology and medical device industries. Committed toproviding solutions that expedite time-to-market and peak-market penetration,PAREXEL has developed significant expertise across the development andcommercialization continuum, from drug development and regulatory consultingto clinical pharmacology, clinical trials management, medical education andreimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, providesadvanced technology solutions, including medical imaging, to facilitate theclinical development process. Headquartered near Boston, Massachusetts,PAREXEL operates in 69 locations throughout 52 countries around the world, andhas approximately 8,800 employees. For more information about PAREXELInternational visit www.PAREXEL.com.
This release contains "forward-looking" statements regarding futureresults and events. For this purpose, any statements contained herein that arenot statements of historical fact may be deemed forward-looking statements.Without limiting the foregoing, the words "believes," "anticipates," "plans,""expects," "intends," "appears," "estimates," "projects," "targets," andsimilar expressions are also intended to identify forward-looking statements.The forward-looking statements in this release involve a number of risks anduncertainties. The Company's actual future results may differ significantlyfrom the results discussed in the forward-looking statements contained in thisrelease. Important factors that might cause such a difference include, but arenot limited to, risks associated with: actual operating performance; actualexpense savings and other operating improvements resulting from recentrestructurings; the loss, modification, or delay of contracts which would,among other things, adversely impact the Company's recognition of revenueincluded in backlog; the Company's dependence on certain industries andclients; the Company's ability to win new business, manage growth and costs,and attract and retain employees; the Company's ability to complete additionalacquisitions and to integrate newly acquired businesses or enter into newlines of business, including ClinPhone; the impact on the Company's businessof government regulation of the drug, medical device and biotechnologyindustry; consolidation within the pharmaceutical industry and competitionwithin the biopharmaceutical services industry; the potential for significantliability to clients and third parties; the potential adverse impact of healthcare reform; and the effects of exchange rate fluctuations and otherinternational economic, political, and other risks. Such factors and othersare discussed more fully in the section entitled "Risk Factors" of theCompany's Annual Report on Form 10-K for the Fiscal Year ended June 30, 2008as filed with the SEC on August 28, 2008, which "Risk Factors" discussion isincorporated by reference in this press release. The forward-lookingstatements included in this press release represent the Company's estimates asof the date of this release. The Company specifically disclaims any obligationto update these forward-looking statements in the future. These forward-looking statements should not be relied upon as representing the Company'sestimates or views as of any date subsequent to the date of this pressrelease.
PAREXEL is a registered trademark of PAREXEL International Corporation,and Perceptive Informatics is a trademark of Perceptive Informatics, Inc. Allother names or marks may be registered trademarks or trademarks of theirrespective business and are hereby acknowledged.Contacts: Jennifer Baird, Rebecca Passo Senior Director of Public Relations SHIFT Communications PAREXEL International Tel: +617-779-1817 Tel: +781-434-4409 Email: [email protected] Email: [email protected]
SOURCE PAREXEL International
